Literature DB >> 24408053

Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome.

Andrea Rebellato1, Andrea Grillo, Francesca Dassie, Nicoletta Sonino, Pietro Maffei, Chiara Martini, Agostino Paoletta, Bruno Fabris, Renzo Carretta, Francesco Fallo.   

Abstract

Cushing's syndrome is associated with high cardiovascular morbility and mortality. Blood pressure (BP) variability within a 24-h period is increasingly recognized as an independent predictor of cardiovascular risk. The aim of our study was to investigate the short-term BP variability indices in Cushing's syndrome. Twenty-five patients with Cushing's syndrome (mean age 49 ± 13 years, 4 males; 21 Cushing's disease and 4 adrenal adenoma patients) underwent 24-h ambulatory BP monitoring (ABPM) and evaluation of cardiovascular risk factors. Cushing patients were divided into 8 normotensive (NOR-CUSH) and 17 hypertensive (HYP-CUSH) patients and were compared with 20 normotensive (NOR-CTR) and 20 hypertensive (HYP-CTR) age-, sex-, and BMI-matched control subjects. Short-term BP variability was derived from ABPM and calculated as the following: (1) standard deviation (SD) of 24-h, daytime, and nighttime BP; (2) 24-h weighted SD of BP; and (3) average real variability (ARV), i.e., the average of the absolute differences between consecutive BP measurements over 24 h. In comparison with controls, patients with Cushing's syndrome, either normotensive or hypertensive, had higher 24-h and daytime SD of BP, as well as higher 24-h weighted SD and ARV of BP (P = 0.03 to P < 0.0001). No difference in metabolic parameters was observed between NOR-CTR and NOR-CUSH or between HYP-CTR and HYP-CUSH subgroups. ABPM-derived short-term BP variability is increased in Cushing's syndrome, independent of BP elevation. It may represent an additional cardiovascular risk factor in this disease. The role of excess cortisol in BP variability has to be further clarified.

Entities:  

Mesh:

Year:  2014        PMID: 24408053     DOI: 10.1007/s12020-014-0164-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  42 in total

Review 1.  Cushing's syndrome.

Authors:  M Boscaro; L Barzon; F Fallo; N Sonino
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

2.  Identification of an increased short-term blood pressure variability on ambulatory blood pressure monitoring as a coronary risk factor in diabetic hypertensives.

Authors:  Motoko Ozawa; Kouichi Tamura; Yasuko Okano; Kouhei Matsushita; Mai Yanagi; Yuko Tsurumi-Ikeya; Jin Oshikawa; Tatsuo Hashimoto; Shinichiro Masuda; Hiromichi Wakui; Atsu-Ichiro Shigenaga; Kouichi Azuma; Tomoaki Ishigami; Yoshiyuki Toya; Toshiyuki Ishikawa; Satoshi Umemura
Journal:  Clin Exp Hypertens       Date:  2009-05       Impact factor: 1.749

Review 3.  Glucocorticoid-induced hypertension.

Authors:  Julie E Goodwin; David S Geller
Journal:  Pediatr Nephrol       Date:  2011-07-09       Impact factor: 3.714

Review 4.  How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids.

Authors:  Sharon L H Ong; Judith A Whitworth
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

5.  Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors.

Authors:  N Albiger; R M Testa; B Almoto; M Ferrari; F Bilora; F Petrobelli; A Pagnan; F Mantero; C Scaroni
Journal:  Horm Metab Res       Date:  2006-06       Impact factor: 2.936

6.  Combined amplification of the pulsatile and basal modes of adrenocorticotropin and cortisol secretion in patients with Cushing's disease: evidence for decreased responsiveness of the adrenal glands.

Authors:  G van den Berg; M Frölich; J D Veldhuis; F Roelfsema
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

Review 7.  Hypertension in Cushing's syndrome: from pathogenesis to treatment.

Authors:  Maria Verena Cicala; Franco Mantero
Journal:  Neuroendocrinology       Date:  2010-09-10       Impact factor: 4.914

8.  Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's Syndrome.

Authors:  Merih Baykan; Cihangir Erem; Omer Gedikli; Arif Hacihasanoglu; Turan Erdogan; Mustafa Kocak; Ismet Durmuş; Levent Korkmaz; Sükrü Celik
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

Review 9.  Mechanisms of cortisol-induced hypertension in humans.

Authors:  J A Whitworth; M A Brown; J J Kelly; P M Williamson
Journal:  Steroids       Date:  1995-01       Impact factor: 2.668

10.  Mechanism of the effects of glucocorticoids and mineralocorticoids on vascular smooth muscle contractility.

Authors:  L Kornel; W A Nelson; B Manisundaram; R Chigurupati; T Hayashi
Journal:  Steroids       Date:  1993-12       Impact factor: 2.668

View more
  4 in total

1.  Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues.

Authors:  A Comunello; F Dassie; C Martini; E De Carlo; R Mioni; M Battocchio; A Paoletta; F Fallo; R Vettor; P Maffei
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

2.  A lack of day-by-day variability in blood pressure in a Cushing's disease patient.

Authors:  K Eguchi; H Kurita; E Matsumoto; M Hashimoto; K Kario
Journal:  J Hum Hypertens       Date:  2017-03-23       Impact factor: 3.012

3.  Clinical Benefits of Unilateral Adrenalectomy in Patients with Subclinical Hypercortisolism Due to Adrenal Incidentaloma: Results from a Single Center.

Authors:  Luigi Petramala; Giuseppe Cavallaro; Matteo Galassi; Cristiano Marinelli; Gianfranco Tonnarini; Antonio Concistrè; Umberto Costi; Maurizio Bufi; Piernatale Lucia; Giuseppe De Vincentis; Gino Iannucci; Giorgio De Toma; Claudio Letizia
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-01-31

4.  Ambulatory Blood Pressure Monitoring-Derived Short-Term Blood Pressure Variability in Primary Aldosteronism.

Authors:  Andrea Grillo; Stella Bernardi; Andrea Rebellato; Bruno Fabris; Moreno Bardelli; Jacopo Burrello; Franco Rabbia; Franco Veglio; Francesco Fallo; Renzo Carretta
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-04-16       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.